Advanced
  Home Compare Reports

Comparison with Similar Reports

Biomarkers Market by Product (Consumable, Service), Type (Safety, Efficacy, Validation), Disease (Cancer (Solid & Liquid Biopsy), Neurological), Appli...

Publisher:        MarketsandMarkets

# of Pages:        231

Rating: 

1 User License $4,950

Publication Date:  July, 2021

Price:       $4,950 / User License




1 INTRODUCTION 31
1.1 OBJECTIVES OF THE STUDY 31
1.2 MARKET DEFINITION 32
1.2.1 INCLUSIONS & EXCLUSIONS 32
1.3 MARKET SCOPE 33
1.3.1 MARKETS COVERED 33
FIGURE 1 BIOMARKERS MARKET SEGMENTATION 33
1.3.2 YEARS CONSIDERED IN THE REPORT 33
1.4 CURRENCY 34
1.5 LIMITATIONS 34
1.6 STAKEHOLDERS 34
1.7 SUMMARY OF CHANGES 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 37
2.1.2 PRIMARY DATA 37
FIGURE 3 PRIMARY SOURCES 38
FIGURE 4 BIOMARKERS MARKET: BREAKDOWN OF PRIMARIES 38
2.1.2.1 Key industry insights 39
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2020 40
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP (SUPPLY SIDE): COLLECTIVE REVENUE OF ALL BIOMARKERS PRODUCTS 41
FIGURE 7 BIOMARKERS MARKET: CAGR PROJECTIONS, 2021–2026 42
FIGURE 8 BIOMARKERS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS OPPORTUNITIES, AND CHALLENGES 43
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 44
FIGURE 9 DATA TRIANGULATION METHODOLOGY 44
2.4 RESEARCH LIMITATIONS 45
2.5 RESEARCH ASSUMPTIONS 45
2.6 RISK ANALYSIS 46
3 EXECUTIVE SUMMARY 47
FIGURE 10 BIOMARKERS MARKET, BY PRODUCT & SERVICE,
2021 VS. 2026 (USD BILLION) 47
FIGURE 11 BIOMARKERS MARKET SHARE, BY TYPE, 2020 48
FIGURE 12 BIOMARKERS MARKET, BY DISEASE INDICATION,
2021 VS. 2026 (USD BILLION) 48
FIGURE 13 BIOMARKERS MARKET, BY APPLICATION, 2021−2026 49
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF THE BIOMARKERS MARKET 50
4 PREMIUM INSIGHTS 51
4.1 BIOMARKERS MARKET OVERVIEW 51
FIGURE 15 THE GROWING IMPORTANCE OF COMPANION DIAGNOSTICS IS A KEY FACTOR EXPECTED TO DRIVE THE GROWTH OF THE BIOMARKERS MARKET 51
4.2 ASIA PACIFIC: BIOMARKERS MARKET, BY PRODUCT & COUNTRY (2020) 52
FIGURE 16 CONSUMABLES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2020 52
4.3 EFFICACY BIOMARKERS MARKET, BY TYPE, 2020 53
FIGURE 17 THE PREDICTIVE BIOMARKERS SEGMENT IS PROJECTED TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 53
5 MARKET OVERVIEW 54
5.1 MARKET DYNAMICS 54
FIGURE 18 BIOMARKERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54
5.1.1 MARKET DRIVERS 55
5.1.1.1 The growing importance of companion diagnostics 55
TABLE 1 RECENT DEVELOPMENTS IN COMPANION DIAGNOSTICS 55
5.1.1.2 Increasing prevalence of cancer worldwide 57
TABLE 2 GLOBAL CANCER INCIDENCE, 2020 VS. 2040 57
TABLE 3 LIST OF FDA-APPROVED BIOMARKERS FOR DIFFERENT TYPES OF CANCER 57
5.1.1.3 Increasing funds & grants for biomarker research 58
5.1.1.4 Continuous product innovations 58
TABLE 4 PRODUCT LAUNCHES, 2018−2021 59
5.1.2 RESTRAINTS 60
5.1.2.1 High capital investments and lengthy timelines for biomarker development 60
TABLE 5 TIMEFRAME FOR BIOMARKER DEVELOPMENT 60
5.1.3 OPPORTUNITIES 61
5.1.3.1 Personalized medicine 61
FIGURE 19 PERCENTAGE OF ONCOLOGY TRIALS INCORPORATING BIOMARKERS 62
TABLE 6 BIOMARKERS OF CARDIOVASCULAR DISEASE (CVD) 62
5.1.3.2 Emerging economies 63
5.1.4 CHALLENGES 63
5.1.4.1 Challenges associated with biomarker validation 63
5.1.4.2 Technical issues related to sample collection & storage 64
5.2 IMPACT OF COVID-19 ON THE BIOMARKERS MARKET 64
5.3 REGULATORY ASSESSMENT 66
5.3.1 INTRODUCTION 66
5.3.2 BIOMARKER QUALIFICATION IN THE US 66
5.3.3 BIOMARKER QUALIFICATION IN THE EU 66
5.3.4 BIOMARKER ACCEPTANCE IN DRUG DEVELOPMENT IN THE EU AND THE US 67
5.3.5 METHOD: EMA APPROVALS 67
5.3.6 METHOD: FDA APPROVALS 67
5.3.7 COMPANION DIAGNOSTICS 68
5.4 VALUE CHAIN ANALYSIS 68
FIGURE 20 BIOMARKERS MARKET: VALUE CHAIN ANALYSIS 68
5.5 TECHNOLOGICAL ANALYSIS 69
5.5.1 IMMUNOASSAYS 69
5.5.1.1 Immunohistochemistry (IHC) 69
5.5.1.2 Flow cytometry 69
5.5.1.3 Flow cytometry ELISA 69
5.5.2 NEXT-GENERATION SEQUENCING (NGS) 70
5.5.3 POLYMERASE CHAIN REACTION (PCR) 70
5.5.4 IN SITU HYBRIDIZATION 70
5.5.5 MICROARRAYS 71
5.5.6 MASS SPECTROMETRY 71
5.6 PORTER’S FIVE FORCES ANALYSIS 71
TABLE 7 BIOMARKERS MARKET- PORTER’S FIVE FORCES ANALYSIS 71
5.6.1 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS 72
5.6.2 BARGAINING POWER OF SUPPLIERS 72
5.6.3 BARGAINING POWER OF BUYERS 72
5.6.4 THREAT OF SUBSTITUTES 72
5.6.5 THREAT OF NEW ENTRANTS 73
5.7 PATENT ANALYSIS 73
5.7.1 NUMBER OF PUBLICATIONS OVER LAST 10 YEARS 73
5.7.2 TOP 20 GRANTED PATENT OWNERS (US) IN LAST 20 YEARS 73
5.7.3 TOP 10 PLAYERS WITH HIGHEST NO. OF PATENT APPLICATIONS 74
5.7.4 LIST OF RECENT PATENTS 74
5.8 SUPPLY CHAIN ANALYSIS 75
FIGURE 21 DIRECT DISTRIBUTION STRATEGY PREFERRED BY PROMINENT COMPANIES 76
5.8.1 KEY INFLUENCERS 76
5.9 ECOSYSTEM ANALYSIS OF THE BIOMARKERS MARKET 76
FIGURE 22 ECOSYSTEM ANALYSIS OF THE BIOMARKERS MARKET 76
5.9.1 ROLE IN THE ECOSYSTEM 77
5.10 Y.C., YCC SHIFT 77
FIGURE 23 YC-YCC SHIFT FOR THE BIOMARKERS MARKET 77
5.11 RANGES/ SCENARIOS 78
FIGURE 24 DEPENDING ON HOW THE UNCERTAINTIES UNFOLD, WE SEE A SPECTRUM OF SCENARIOS FOR THE BIOMARKERS MARKET – 2020 78
 
6 BIOMARKERS MARKET, BY PRODUCT & SERVICE 79
6.1 INTRODUCTION 80
TABLE 8 BIOMARKERS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD BILLION) 80
6.2 CONSUMABLES 80
6.2.1 THE HIGHER FREQUENCY OF REPEATED PURCHASES OF CONSUMABLES TO DRIVE THE MARKET GROWTH 80
TABLE 9 BIOMARKER CONSUMABLES MARKET, BY REGION,
2019–2026 (USD BILLION) 81
TABLE 10 NORTH AMERICA: BIOMARKER CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD BILLION) 81
TABLE 11 EUROPE: BIOMARKER CONSUMABLES MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 81
TABLE 12 ASIA PACIFIC: BIOMARKER CONSUMABLES MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 82
6.3 SERVICES 82
6.3.1 THE GRADUAL SHIFT FROM IN-HOUSE BIOMARKER TESTING TO OUTSOURCING OF SERVICES IS EXPECTED TO SUPPORT MARKET GROWTH 82
TABLE 13 BIOMARKER SERVICES MARKET, BY REGION, 2019–2026 (USD BILLION) 83
TABLE 14 NORTH AMERICA: BIOMARKER SERVICES MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 83
TABLE 15 EUROPE: BIOMARKER SERVICES MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 83
TABLE 16 ASIA PACIFIC: BIOMARKER SERVICES MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 84
6.4 SOFTWARE 84
6.4.1 INCREASING ADOPTION OF BIOINFORMATICS TOOLS BY PHARMACEUTICAL COMPANIES TO SUPPORT THE MARKET GROWTH 84
TABLE 17 BIOMARKER SOFTWARE MARKET, BY REGION, 2019–2026 (USD BILLION) 84
TABLE 18 NORTH AMERICA: BIOMARKER SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD BILLION) 85
TABLE 19 EUROPE: BIOMARKER SOFTWARE MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 85
TABLE 20 ASIA PACIFIC: BIOMARKER SOFTWARE MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 85
7 BIOMARKERS MARKET, BY TYPE 86
7.1 INTRODUCTION 87
TABLE 21 BIOMARKERS MARKET, BY TYPE, 2019–2026 (USD BILLION) 87
7.2 EFFICACY BIOMARKERS 87
TABLE 22 EFFICACY BIOMARKERS MARKET, BY TYPE, 2019–2026 (USD BILLION) 87
TABLE 23 EFFICACY BIOMARKERS MARKET, BY REGION, 2019–2026 (USD BILLION) 88
TABLE 24 NORTH AMERICA: EFFICACY BIOMARKERS MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 88
TABLE 25 EUROPE: EFFICACY BIOMARKERS MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 88
TABLE 26 ASIA PACIFIC: EFFICACY BIOMARKERS MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 89
7.2.1 PREDICTIVE BIOMARKERS 89
7.2.1.1 Wide applications of predictive biomarkers in personalized medicine and companion diagnostics drive the growth of this segment 89
TABLE 27 PREDICTIVE BIOMARKERS MARKET, BY REGION, 2019–2026 (USD BILLION) 89
TABLE 28 NORTH AMERICA: PREDICTIVE BIOMARKERS MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 90
TABLE 29 EUROPE: PREDICTIVE BIOMARKERS MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 90
TABLE 30 ASIA PACIFIC: PREDICTIVE BIOMARKERS MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 90
7.2.2 SURROGATE BIOMARKERS 91
7.2.2.1 The use of surrogate biomarkers helps accelerate drug development and shorten timelines for regulatory approval 91
TABLE 31 SURROGATE BIOMARKERS MARKET, BY REGION, 2019–2026 (USD BILLION) 91
TABLE 32 NORTH AMERICA: SURROGATE BIOMARKERS MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 91
TABLE 33 EUROPE: SURROGATE BIOMARKERS MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 92
TABLE 34 ASIA PACIFIC: SURROGATE BIOMARKERS MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 92
7.2.3 PHARMACODYNAMIC BIOMARKERS 92
7.2.3.1 Increasing utilization of pharmacodynamic biomarkers in the selection & optimization of drug doses supports segment growth 92
TABLE 35 PHARMACODYNAMIC BIOMARKERS MARKET, BY REGION,
2019–2026 (USD BILLION) 93
TABLE 36 NORTH AMERICA: PHARMACODYNAMIC BIOMARKERS MARKET,
BY COUNTRY, 2019–2026 (USD BILLION) 93
TABLE 37 . EUROPE: PHARMACODYNAMIC BIOMARKERS MARKET, BY COUNTRY, 2019–2026 (USD BILLION) 93
TABLE 38 ASIA PACIFIC: PHARMACODYNAMIC BIOMARKERS MARKET, BY COUNTRY, 2019–2026 (USD BILLION) 94
7.2.4 PROGNOSTIC BIOMARKERS 94
7.2.4.1 Prognostic biomarkers help in predicting the recurrence of diseases 94
TABLE 39 PROGNOSTIC BIOMARKERS MARKET, BY REGION,
2019–2026 (USD BILLION) 94
TABLE 40 NORTH AMERICA: PROGNOSTIC BIOMARKERS MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 95
TABLE 41 EUROPE: PROGNOSTIC BIOMARKERS MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 95
TABLE 42 ASIA PACIFIC: PROGNOSTIC BIOMARKERS MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 95
7.3 SAFETY BIOMARKERS 96
7.3.1 WIDE APPLICATIONS OF SAFETY BIOMARKERS IN DRUG DISCOVERY & DEVELOPMENT IS EXPECTED TO FUEL MARKET GROWTH 96
TABLE 43 SAFETY BIOMARKERS MARKET, BY REGION, 2019–2026 (USD BILLION) 96
TABLE 44 NORTH AMERICA: SAFETY BIOMARKERS MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 96
TABLE 45 EUROPE: SAFETY BIOMARKERS MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 97
TABLE 46 ASIA PACIFIC: SAFETY BIOMARKERS MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 97
7.4 VALIDATION BIOMARKERS 97
7.4.1 VALIDATION BIOMARKERS ENABLE IN THE EVALUATION OF
DIAGNOSTIC SYSTEMS 97
TABLE 47 VALIDATION BIOMARKERS MARKET, BY REGION, 2019–2026 (USD BILLION) 98
TABLE 48 NORTH AMERICA: VALIDATION BIOMARKERS MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 98
TABLE 49 EUROPE: VALIDATION BIOMARKERS MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 98
TABLE 50 ASIA PACIFIC: VALIDATION BIOMARKERS MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 99
8 BIOMARKERS MARKET, BY DISEASE INDICATION 100
8.1 INTRODUCTION 101
TABLE 51 BIOMARKERS MARKET, BY DISEASE INDICATION, 2019–2026 (USD BILLION) 101
8.2 CANCER 101
8.2.1 INCREASING ADOPTION OF BIOMARKERS IN CANCER RESEARCH & DIAGNOSIS IS EXPECTED TO DRIVE THE MARKET GROWTH 101
TABLE 52 LIST OF FDA-APPROVED BIOMARKERS FOR CANCER 102
TABLE 53 BIOMARKERS MARKET FOR CANCER, BY REGION,
2019–2026 (USD BILLION) 102
TABLE 54 NORTH AMERICA: BIOMARKERS MARKET FOR CANCER, BY COUNTRY,
2019–2026 (USD BILLION) 102
TABLE 55 EUROPE: BIOMARKERS MARKET FOR CANCER, BY COUNTRY,
2019–2026 (USD BILLION) 103
TABLE 56 ASIA PACIFIC: BIOMARKERS MARKET FOR CANCER, BY COUNTRY,
2019–2026 (USD BILLION) 103
8.2.2 SOLID BIOPSY 103
8.2.2.1 Solid biopsy provides the mutations from within the tumors 103
8.2.3 LIQUID BIOPSY 104
8.2.3.1 A liquid biopsy helps detect circulating tumor cells 104
TABLE 57 CANCER DISEASE INDICATION MARKET, BY TEST TYPE,
2019–2026 (USD BILLION) 104
8.3 INFECTIOUS DISEASES 104
8.3.1 THE INCREASING PREVALENCE OF INFECTIOUS DISEASES ARE EXPECTED TO INCREASE THE DEMAND FOR BIOMARKERS 104
TABLE 58 BIOMARKERS MARKET FOR INFECTIOUS DISEASES, BY REGION,
2019–2026 (USD BILLION) 105
TABLE 59 NORTH AMERICA: BIOMARKERS MARKET FOR INFECTIOUS DISEASES,
BY COUNTRY, 2019–2026 (USD BILLION) 105
TABLE 60 EUROPE: BIOMARKERS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2019–2026 (USD BILLION) 106
TABLE 61 ASIA PACIFIC: BIOMARKERS MARKET FOR INFECTIOUS DISEASES,
BY COUNTRY, 2019–2026 (USD BILLION) 106
8.4 IMMUNOLOGICAL DISORDERS 106
8.4.1 INCREASING ADOPTION OF BIOMARKERS FOR VARIOUS IMMUNOLOGICAL DISORDERS ARE EXPECTED TO DRIVE THE MARKET GROWTH 106
TABLE 62 BIOMARKERS FOR IMMUNOLOGICAL DISORDERS 107
TABLE 63 BIOMARKERS MARKET FOR IMMUNOLOGICAL DISORDERS, BY REGION, 2019–2026 (USD BILLION) 107
TABLE 64 NORTH AMERICA: BIOMARKERS MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2019–2026 (USD BILLION) 108
TABLE 65 EUROPE: BIOMARKERS MARKET FOR IMMUNOLOGICAL DISORDERS,
BY COUNTRY, 2019–2026 (USD BILLION) 108
TABLE 66 ASIA PACIFIC: BIOMARKERS MARKET FOR IMMUNOLOGICAL DISORDERS,
BY COUNTRY, 2019–2026 (USD BILLION) 108
8.5 NEUROLOGICAL DISORDERS 109
8.5.1 IMMUNOASSAYS ARE WIDELY USED IN THE DIAGNOSIS OF NEUROLOGICAL DISORDERS 109
TABLE 67 BIOMARKERS MARKET FOR NEUROLOGICAL DISORDERS, BY REGION, 2019–2026 (USD BILLION) 109
TABLE 68 NORTH AMERICA: BIOMARKERS MARKET FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2019–2026 (USD BILLION) 109
TABLE 69 EUROPE: BIOMARKERS MARKET FOR NEUROLOGICAL DISORDERS,
BY COUNTRY, 2019–2026 (USD BILLION) 110
TABLE 70 ASIA PACIFIC: BIOMARKERS MARKET FOR NEUROLOGICAL DISORDERS,
BY COUNTRY, 2019–2026 (USD BILLION) 110
8.6 CARDIOVASCULAR DISORDERS 110
8.6.1 THE INCREASING PREVALENCE OF CVD IS EXPECTED TO INCREASE THE DEMAND FOR CARDIAC BIOMARKERS 110
TABLE 71 BIOMARKERS FOR CARDIOVASCULAR DISORDERS 111
TABLE 72 BIOMARKERS MARKET FOR CARDIOVASCULAR DISORDERS, BY REGION, 2019–2026 (USD BILLION) 111
TABLE 73 NORTH AMERICA: BIOMARKERS MARKET FOR CARDIOVASCULAR DISORDERS, BY COUNTRY, 2019–2026 (USD BILLION) 111
TABLE 74 EUROPE: BIOMARKERS MARKET FOR CARDIOVASCULAR DISORDERS,
BY COUNTRY, 2019–2026 (USD BILLION) 112
TABLE 75 ASIA PACIFIC: BIOMARKERS MARKET FOR CARDIOVASCULAR DISORDERS, BY COUNTRY, 2019–2026 (USD BILLION) 112
8.7 OTHER DISEASE INDICATIONS 112
TABLE 76 BIOMARKERS FOR RENAL DISORDERS 113
TABLE 77 ENDOCRINE BIOMARKERS 113
TABLE 78 BIOMARKERS MARKET FOR OTHER DISEASE INDICATIONS, BY REGION, 2019–2026 (USD BILLION) 114
TABLE 79 NORTH AMERICA: BIOMARKERS MARKET FOR OTHER DISEASE INDICATIONS, BY COUNTRY, 2019–2026 (USD BILLION) 114
TABLE 80 EUROPE: BIOMARKERS MARKET FOR OTHER DISEASE INDICATIONS,
BY COUNTRY, 2019–2026 (USD BILLION) 114
TABLE 81 ASIA PACIFIC: BIOMARKERS MARKET SIZE FOR OTHER DISEASE INDICATIONS, BY COUNTRY, 2019–2026 (USD BILLION) 115
9 BIOMARKERS MARKET, BY APPLICATION 116
9.1 INTRODUCTION 117
TABLE 82 BIOMARKERS MARKET, BY APPLICATION, 2019–2026 (USD BILLION) 117
9.2 DIAGNOSTICS 117
9.2.1 THE INCREASING USE OF BIOMARKERS FOR THE DIAGNOSIS OF VARIOUS DISEASES TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT 117
TABLE 83 BIOMARKERS MARKET FOR DIAGNOSTICS, BY REGION,
2019–2026 (USD BILLION) 118
TABLE 84 NORTH AMERICA: BIOMARKERS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD BILLION) 118
TABLE 85 EUROPE: BIOMARKERS MARKET FOR DIAGNOSTICS, BY COUNTRY,
2019–2026 (USD BILLION) 118
TABLE 86 ASIA PACIFIC: BIOMARKERS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD BILLION) 119
9.3 DRUG DISCOVERY & DEVELOPMENT 119
9.3.1 BIOMARKERS PLAY A KEY ROLE AS BIOLOGICAL INDICATORS IN THE DEVELOPMENT OF NEW DRUGS 119
TABLE 87 BIOMARKERS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2019–2026 (USD BILLION) 120
TABLE 88 NORTH AMERICA: BIOMARKERS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD BILLION) 120
TABLE 89 EUROPE: BIOMARKERS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD BILLION) 120
TABLE 90 ASIA PACIFIC: BIOMARKERS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD BILLION) 121
9.4 PERSONALIZED MEDICINE 121
9.4.1 INCREASING APPLICATIONS OF BIOMARKERS IN PERSONALIZED MEDICINE FOR TARGETED THERAPIES DRIVES THE MARKET GROWTH 121
TABLE 91 SELECTED PERSONALIZED MEDICINE DRUGS AND RELEVANT BIOMARKERS 121
TABLE 92 BIOMARKERS MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2019–2026 (USD BILLION) 122
TABLE 93 NORTH AMERICA: BIOMARKERS MARKET FOR PERSONALIZED MEDICINE,
BY COUNTRY, 2019–2026 (USD BILLION) 122
TABLE 94 EUROPE: BIOMARKERS MARKET FOR PERSONALIZED MEDICINE,
BY COUNTRY, 2019–2026 (USD BILLION) 122
TABLE 95 ASIA PACIFIC: BIOMARKERS MARKET FOR PERSONALIZED MEDICINE,
BY COUNTRY, 2019–2026 (USD BILLION) 123
9.5 DISEASE RISK ASSESSMENT 123
9.5.1 BIOMARKERS ARE WIDELY USED FOR THE CHARACTERIZATION OF TOXICITY IN DISEASE DIAGNOSIS & DRUG DEVELOPMENT PROCESSES 123
TABLE 96 BIOMARKERS MARKET FOR DISEASE RISK ASSESSMENT, BY REGION,
2019–2026 (USD BILLION) 124
TABLE 97 NORTH AMERICA: BIOMARKERS MARKET FOR DISEASE RISK ASSESSMENT, BY COUNTRY, 2019–2026 (USD BILLION) 124
TABLE 98 EUROPE: BIOMARKERS MARKET FOR DISEASE RISK ASSESSMENT,
BY COUNTRY, 2019–2026 (USD BILLION) 124
TABLE 99 ASIA PACIFIC: BIOMARKERS MARKET FOR DISEASE RISK ASSESSMENT,
BY COUNTRY, 2019–2026 (USD BILLION) 125
9.6 OTHER APPLICATIONS 125
TABLE 100 BIOMARKERS MARKET FOR OTHER APPLICATIONS, BY REGION,
2019–2026 (USD BILLION) 125
TABLE 101 NORTH AMERICA: BIOMARKERS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2019–2026 (USD BILLION) 126
TABLE 102 EUROPE: BIOMARKERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD BILLION) 126
TABLE 103 ASIA PACIFIC: BIOMARKERS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2019–2026 (USD BILLION) 126
10 BIOMARKERS MARKET, BY REGION 127
10.1 INTRODUCTION 128
TABLE 104 BIOMARKERS MARKET, BY REGION, 2019–2026 (USD BILLION) 128
10.2 NORTH AMERICA 128
FIGURE 25 NORTH AMERICA: MARKET SNAPSHOT 129
TABLE 105 NORTH AMERICA: BIOMARKERS MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 130
TABLE 106 NORTH AMERICA: BIOMARKERS MARKET, BY PRODUCT,
2019–2026 (USD BILLION) 130
TABLE 107 NORTH AMERICA: BIOMARKERS MARKET, BY TYPE,
2019–2026 (USD BILLION) 130
TABLE 108 NORTH AMERICA: EFFICACY BIOMARKERS MARKET, BY TYPE,
2019–2026 (USD BILLION) 130
TABLE 109 NORTH AMERICA: BIOMARKERS MARKET, BY APPLICATION,
2019–2026 (USD BILLION) 131
TABLE 110 NORTH AMERICA: BIOMARKERS MARKET, BY DISEASE INDICATION,
2019–2026 (USD BILLION) 131
10.2.1 US 131
10.2.1.1 The US is expected to dominate the biomarkers market in North America during the forecast period 131
TABLE 111 US.: BIOMARKERS MARKET, BY PRODUCT, 2019–2026 (USD BILLION) 133
TABLE 112 US: BIOMARKERS MARKET, BY TYPE, 2019–2026 (USD BILLION) 133
TABLE 113 US: EFFICACY BIOMARKERS MARKET, BY TYPE, 2019–2026 (USD BILLION) 133
TABLE 114 US: BIOMARKERS MARKET, BY APPLICATION, 2019–2026 (USD BILLION) 134
TABLE 115 US: BIOMARKERS MARKET, BY DISEASE INDICATION,
2019–2026 (USD BILLION) 134
10.2.2 CANADA 134
10.2.2.1 The increasing incidence of cancer drives the growth of biomarker research in Canada 134
TABLE 116 CANADA: BIOMARKERS MARKET, BY PRODUCT, 2019–2026 (USD BILLION) 135
TABLE 117 CANADA: BIOMARKERS MARKET, BY TYPE, 2019–2026 (USD BILLION) 135
TABLE 118 CANADA: EFFICACY BIOMARKERS MARKET, BY TYPE,
2019–2026 (USD BILLION) 136
TABLE 119 CANADA: BIOMARKERS MARKET, BY APPLICATION,
2019–2026 (USD BILLION) 136
TABLE 120 CANADA: BIOMARKERS MARKET, BY DISEASE INDICATION,
2019–2026 (USD BILLION) 136
10.3 EUROPE 137
TABLE 121 EUROPE: BIOMARKERS MARKET, BY COUNTRY, 2019–2026 (USD BILLION) 137
TABLE 122 EUROPE: BIOMARKERS MARKET, BY PRODUCT, 2019–2026 (USD BILLION) 137
TABLE 123 EUROPE: BIOMARKERS MARKET, BY TYPE, 2019–2026 (USD BILLION) 138
TABLE 124 EUROPE: EFFICACY BIOMARKERS MARKET, BY TYPE,
2019–2026 (USD BILLION) 138
TABLE 125 EUROPE: BIOMARKERS MARKET, BY APPLICATION,
2019–2026 (USD BILLION) 138
TABLE 126 EUROPE: BIOMARKERS MARKET, BY DISEASE INDICATION,
2019–2026 (USD BILLION) 139
10.3.1 GERMANY 139
10.3.1.1 Increasing government funding for biomarker research drives the market growth in Germany 139
TABLE 127 GERMANY: BIOMARKERS MARKET, BY PRODUCT, 2019–2026 (USD BILLION) 139
TABLE 128 GERMANY: BIOMARKERS MARKET, BY TYPE, 2019–2026 (USD BILLION) 140
TABLE 129 GERMANY: EFFICACY BIOMARKERS MARKET, BY TYPE,
2019–2026 (USD BILLION) 140
TABLE 130 GERMANY: BIOMARKERS MARKET, BY APPLICATION,
2019–2026 (USD BILLION) 140
TABLE 131 GERMANY: BIOMARKERS MARKET, BY DISEASE INDICATION,
2019–2026 (USD BILLION) 141
10.3.2 UK 141
10.3.2.1 Availability of government funding and strategic collaborations with biotech firms have significantly boosted the adoption of biomarkers in the UK 141
TABLE 132 UK: BIOMARKERS MARKET, BY PRODUCT, 2019–2026 (USD BILLION) 142
TABLE 133 UK: BIOMARKERS MARKET, BY TYPE, 2019–2026 (USD BILLION) 142
TABLE 134 UK: EFFICACY BIOMARKERS MARKET, BY TYPE, 2019–2026 (USD BILLION) 142
TABLE 135 UK: BIOMARKERS MARKET, BY APPLICATION, 2019–2026 (USD BILLION) 143
TABLE 136 UK: BIOMARKERS MARKET, BY DISEASE INDICATION,
2019–2026 (USD BILLION) 143
10.3.3 FRANCE 143
10.3.3.1 Increasing government investments in genomics & proteomics research to drive the market growth 143
TABLE 137 FRANCE: BIOMARKERS MARKET, BY PRODUCT, 2019–2026 (USD BILLION) 144
TABLE 138 FRANCE: BIOMARKERS MARKET, BY TYPE, 2019–2026 (USD BILLION) 144
TABLE 139 FRANCE: EFFICACY BIOMARKERS MARKET, BY TYPE,
2019–2026 (USD BILLION) 144
TABLE 140 FRANCE: BIOMARKERS MARKET, BY APPLICATION,
2019–2026 (USD BILLION) 145
TABLE 141 FRANCE: BIOMARKERS MARKET, BY DISEASE INDICATION,
2019–2026 (USD BILLION) 145
10.3.4 REST OF EUROPE (ROE) 145
TABLE 142 ROE: BIOMARKERS MARKET, BY PRODUCT, 2019–2026 (USD BILLION) 146
TABLE 143 ROE: BIOMARKERS MARKET, BY TYPE, 2019–2026 (USD BILLION) 146
TABLE 144 ROE: EFFICACY BIOMARKERS MARKET, BY TYPE, 2019–2026 (USD BILLION) 146
TABLE 145 ROE: BIOMARKERS MARKET, BY APPLICATION, 2019–2026 (USD BILLION) 147
TABLE 146 ROE: BIOMARKERS MARKET, BY DISEASE INDICATION,
2019–2026 (USD BILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 26 ASIA PACIFIC: MARKET SNAPSHOT 148
TABLE 147 ASIA PACFIC: BIOMARKERS MARKET, BY COUNTRY,
2019–2026 (USD BILLION) 149
TABLE 148 ASIA PACIFIC: BIOMARKERS MARKET, BY PRODUCT,
2019–2026 (USD BILLION) 149
TABLE 149 ASIA PACIFIC: BIOMARKERS MARKET, BY TYPE, 2019–2026 (USD BILLION) 149
TABLE 150 ASIA PACIFIC: EFFICACY BIOMARKERS MARKET, BY TYPE,
2019–2026 (USD BILLION) 150
TABLE 151 ASIA PACIFIC: BIOMARKERS MARKET, BY APPLICATION,
2019–2026 (USD BILLION) 150
TABLE 152 ASIA PACIFIC: BIOMARKERS MARKET, BY DISEASE INDICATION,
2019–2026 (USD BILLION) 151
10.4.1 CHINA 151
10.4.1.1 The increasing burden of diseases and growing focus on the development of novel drugs are expected to drive the demand for biomarkers in China 151
TABLE 153 CHINA: BIOMARKERS MARKET, BY PRODUCT, 2019–2026 (USD BILLION) 152
TABLE 154 CHINA: BIOMARKERS MARKET, BY TYPE, 2019–2026 (USD BILLION) 152
TABLE 155 CHINA: EFFICACY BIOMARKERS MARKET, BY TYPE,
2019–2026 (USD BILLION) 152
TABLE 156 CHINA: BIOMARKERS MARKET, BY APPLICATION, 2019–2026 (USD BILLION) 153
TABLE 157 CHINA: BIOMARKERS MARKET, BY DISEASE INDICATION,
2019–2026 (USD BILLION) 153
10.4.2 JAPAN 153
10.4.2.1 Strategic collaborations with leading pharmaceutical companies drive the market growth in Japan 153
TABLE 158 JAPAN: BIOMARKERS MARKET, BY PRODUCT, 2019–2026 (USD BILLION) 154
TABLE 159 JAPAN: BIOMARKERS MARKET, BY TYPE, 2019–2026 (USD BILLION) 155
TABLE 160 JAPAN: EFFICACY BIOMARKERS MARKET, BY TYPE,
2019–2026 (USD BILLION) 155
TABLE 161 JAPAN: BIOMARKERS MARKET, BY APPLICATION, 2019–2026 (USD BILLION) 155
TABLE 162 JAPAN: BIOMARKERS MARKET, BY DISEASE INDICATION,
2019–2026 (USD BILLION) 156
10.4.3 INDIA 156
10.4.3.1 The growing prevalence of target diseases is expected to support the biomarkers market in India 156
TABLE 163 INDIA: BIOMARKERS MARKET, BY PRODUCT, 2019–2026 (USD BILLION) 156
TABLE 164 INDIA: BIOMARKERS MARKET, BY TYPE, 2019–2026 (USD BILLION) 157
TABLE 165 INDIA: EFFICACY BIOMARKERS MARKET, BY TYPE,
2019–2026 (USD BILLION) 157
TABLE 166 INDIA: BIOMARKERS MARKET, BY APPLICATION, 2019–2026 (USD BILLION) 157
TABLE 167 INDIA: BIOMARKERS MARKET, BY DISEASE INDICATION,
2019–2026 (USD BILLION) 158
10.4.4 REST OF ASIA PACIFIC (ROAPAC) 158
TABLE 168 ROAPAC: BIOMARKERS MARKET, BY PRODUCT, 2019–2026 (USD BILLION) 159
TABLE 169 ROAPAC: BIOMARKERS MARKET, BY TYPE, 2019–2026 (USD BILLION) 159
TABLE 170 ROAPAC: EFFICACY BIOMARKERS MARKET, BY TYPE,
2019–2026 (USD BILLION) 159
TABLE 171 ROAPAC: BIOMARKERS MARKET, BY APPLICATION,
2019–2026 (USD BILLION) 160
TABLE 172 ROAPAC: BIOMARKERS MARKET, BY DISEASE INDICATION,
2019–2026 (USD BILLION) 160
10.5 REST OF THE WORLD (ROW) 160
TABLE 173 ROW: BIOMARKERS MARKET, BY PRODUCT, 2019–2026 (USD BILLION) 161
TABLE 174 ROW: BIOMARKERS MARKET, BY TYPE, 2019–2026 (USD BILLION) 161
TABLE 175 ROW: EFFICACY BIOMARKERS MARKET, BY TYPE, 2019–2026 (USD BILLION) 161
TABLE 176 ROW: BIOMARKERS MARKET, BY APPLICATION, 2019–2026 (USD BILLION) 162
TABLE 177 ROW: BIOMARKERS MARKET, BY DISEASE INDICATION,
2019–2026 (USD BILLION) 162
10.5.1 LATIN AMERICA (LATAM) 162
10.5.1.1 Availability of research funding and the rising awareness of advanced sequencing technologies drives the market growth in LATAM 162
TABLE 178 LATAM: BIOMARKERS MARKET, BY PRODUCT, 2019–2026 (USD BILLION) 163
TABLE 179 LATAM: BIOMARKERS MARKET, BY TYPE, 2019–2026 (USD BILLION) 163
TABLE 180 LATAM: EFFICACY BIOMARKERS MARKET, BY TYPE,
2019–2026 (USD BILLION) 163
TABLE 181 LATAM: BIOMARKERS MARKET, BY APPLICATION, 2019–2026 (USD BILLION) 164
TABLE 182 LATAM: BIOMARKERS MARKET, BY DISEASE INDICATION,
2019–2026 (USD BILLION) 164
10.5.2 MIDDLE EAST AND AFRICA (MEA) 164
10.5.2.1 Increasing focus on proteomics & genomics research supports market growth in the MEA 164
TABLE 183 MEA: BIOMARKERS MARKET, BY PRODUCT, 2019–2026 (USD BILLION) 165
TABLE 184 MEA: BIOMARKERS MARKET, BY TYPE, 2019–2026 (USD BILLION) 165
TABLE 185 MEA: EFFICACY BIOMARKERS MARKET, BY TYPE, 2019–2026 (USD BILLION) 165
TABLE 186 MEA: BIOMARKERS MARKET, BY APPLICATION, 2019–2026 (USD BILLION) 166
TABLE 187 MEA: BIOMARKERS MARKET, BY DISEASE INDICATION,
2019–2026 (USD BILLION) 166
11 COMPETITIVE LANDSCAPE 167
11.1 KEY PLAYER STRATEGIES 167
11.1.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY BIOMARKERS PLAYERS 168
11.2 MARKET SHARE ANALYSIS 169
FIGURE 27 BIOMARKERS MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2020 169
TABLE 188 BIOMARKERS MARKET: DEGREE OF COMPETITION 169
11.3 REVENUE ANALYSIS 170
FIGURE 28 REVENUE ANALYSIS FOR KEY COMPANIES (2017-2020) 170
11.4 COMPANY EVALUATION QUADRANT 171
FIGURE 29 BIOMARKERS MARKET (GLOBAL) COMPANY EVALUATION MATRIX, 2020 171
11.4.1 STAR 172
11.4.2 PERVASIVE 172
11.4.3 EMERGING LEADER 172
11.4.4 PARTICIPANT 172
11.5 COMPETITIVE LEADERSHIP MAPPING (START-UPS) (2020) 173
11.5.1 PROGRESSIVE COMPANIES 173
11.5.2 STARTING BLOCKS 173
11.5.3 DYNAMIC COMPANIES 173
11.5.4 RESPONSIVE COMPANIES 173
FIGURE 30 COMPETITIVE LEADERSHIP MAPPING: BIOMARKERS MARKET 174
11.5.4.1 COMPETITIVE BENCHMARKING 175
TABLE 189 COMPANY PRODUCT FOOTPRINT (25 COMPANIES) 175
TABLE 190 COMPANY APPLICATION FOOTPRINT (25 COMPANIES) 176
TABLE 191 COMPANY REGION FOOTPRINT (25 COMPANIES) 177
TABLE 192 COMPANY FOOTPRINT (25 COMPANIES) 178
11.6 COMPETITIVE SCENARIO 180
11.6.1 PRODUCT LAUNCHES 180
TABLE 193 BIOMARKERS MARKET: PRODUCT LAUNCHES, JANUARY 2018-MAY 2021 180
11.6.2 DEALS 181
TABLE 194 BIOMARKERS MARKET: DEALS, JANUARY 2018-MAY 2021 181
11.6.3 OTHERS 182
12 COMPANY PROFILES 184
12.1 KEY COMPANIES 184
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 F. HOFFMANN-LA ROCHE LTD 184
TABLE 195 HOFFMANN-LA ROCHE LTD: BUSINESS OVERVIEW 184
FIGURE 31 COMPANY SNAPSHOT: HOFFMANN-LA ROCHE LTD (2020) 185
TABLE 196 HOFFMANN-LA ROCHE LTD: PRODUCT OFFERINGS 186
TABLE 197 HOFFMANN-LA ROCHE LTD: PRODUCT LAUNCHES & APPROVALS 187
12.1.2 THERMO FISHER SCIENTIFIC INC. 189
TABLE 198 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 189
FIGURE 32 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC INC (2020) 190
TABLE 199 THERMO FISHER SCIENTIFIC INC.: PRODUCT/SERVICE OFFERINGS 191
TABLE 200 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES & APPROVALS 192
TABLE 201 THERMO FISHER SCIENTIFIC INC.: DEALS 193
TABLE 202 THERMO FISHER SCIENTIFIC INC.: OTHERS 194
12.1.3 ABBOTT LABORATORIES 195
TABLE 203 ABBOTT LABORATORIES: BUSINESS OVERVIEW 195
FIGURE 33 COMPANY SNAPSHOT: ABBOTT LABORATORIES (2020) 196
TABLE 204 ABBOTT LABORATORIES: PRODUCT OFFERINGS 197
TABLE 205 ABBOTT LABORATORIES: PRODUCT LAUNCHES 198
12.1.4 QIAGEN N.V. 199
TABLE 206 QIAGEN N.V.: BUSINESS OVERVIEW 199
FIGURE 34 COMPANY SNAPSHOT: QIAGEN N.V. (2020) 200
TABLE 207 QIAGEN N.V.: PRODUCT/SERVICE OFFERINGS 201
TABLE 208 QIAGEN N.V.: PRODUCT LAUNCHES 202
TABLE 209 QIAGEN N.V.: DEALS 203
12.1.5 PERKINELMER, INC. 204
TABLE 210 PERKINELMER, INC.: BUSINESS OVERVIEW 204
FIGURE 35 COMPANY SNAPSHOT: PERKINELMER, INC. (2020) 205
TABLE 211 PERKINELMER, INC.: PRODUCT/SERVICE OFFERINGS 205
TABLE 212 PERKINELMER, INC.: DEALS 206
12.1.6 MERCK KGAA 207
TABLE 213 MERCK KGAA.: BUSINESS OVERVIEW 207
FIGURE 36 COMPANY SNAPSHOT: MERCK KGAA (2020) 208
TABLE 214 MERCK KGAA: PRODUCT/SERVICE OFFERINGS 208
TABLE 215 MERK KGAA: DEALS 210
TABLE 216 MERCK KGAA: OTHERS 210
12.1.7 BIO-RAD LABORATORIES, INC. 211
TABLE 217 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 211
FIGURE 37 COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC. (2020) 212
TABLE 218 BIO-RAD LABORATORIES, INC.: PRODUCT OFFERINGS 213
12.1.8 ENZO BIOCHEM, INC. 214
TABLE 219 ENZO BIOCHEM, INC.: BUSINESS OVERVIEW 214
FIGURE 38 COMPANY SNAPSHOT: ENZO BIOCHEM, INC. (2020) 215
TABLE 220 ENZO BIOCHEM, INC.: PRODUCT OFFERINGS 216
TABLE 221 ENZO BIOCHEM, INC.: OTHERS 216
12.1.9 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 217
TABLE 222 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: BUSINESS OVERVIEW 217
FIGURE 39 COMPANY SNAPSHOT: CHARLES RIVER LABORATORIES
INTERNATIONAL, INC. (2020) 218
TABLE 223 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: SERVICE OFFERINGS 218
12.1.10 EUROFINS SCIENTIFIC 219
TABLE 224 EUROFINS SCIENTIFIC.: BUSINESS OVERVIEW 219
FIGURE 40 COMPANY SNAPSHOT: EUROFINS SCIENTIFIC (2020) 220
TABLE 225 EUROFINS SCIENTIFIC: SERVICE OFFERINGS 220
12.1.11 MESO SCALE DIAGNOSTICS, LLC. 221
TABLE 226 MESO SCALE DIAGNOSTICS, LLC.: BUSINESS OVERVIEW 221
TABLE 227 MESO SCALE DIAGNOSTICS, LLC: PRODUCT/SERVICE OFFERINGS 221
12.1.12 STRESSMARQ BIOSCIENCES INC. 222
TABLE 228 STRESSMARQ BIOSCIENCES INC.: BUSINESS OVERVIEW 222
TABLE 229 STRESSMARQ BIOSCIENCES INC.: PRODUCT OFFERINGS 222
12.1.13 DIAMETRA 223
TABLE 230 DIAMETRA: BUSINESS OVERVIEW 223
TABLE 231 DIAMETRA: PRODUCT OFFERINGS 223
12.1.14 SIGNOSIS, INC. 224
TABLE 232 SIGNOSIS, INC.: BUSINESS OVERVIEW 224
12.1.15 PRODUCTS OFFERED 224
TABLE 233 SIGNOSIS, INC.: PRODUCT OFFERINGS 224
12.2 OTHER COMPANIES 225
12.2.1 BIOMÉRIEUX SA 225
TABLE 234 BIOMÉRIEUX SA: COMPANY OVERVIEW 225
12.2.2 AXON MEDCHEM BV 226
TABLE 235 AXON MEDCHEM BV: COMPANY OVERVIEW 226
12.2.3 EKF DIAGNOSTICS HOLDINGS, PLC 227
TABLE 236 EKF DIAGNOSTICS HOLDINGS, PLC: COMPANY OVERVIEW 227
12.2.4 MICROCONSTANTS, INC. 227
TABLE 237 MICROCONSTANTS, INC.: COMPANY OVERVIEW 227
12.2.5 NORTHEAST BIOANALYTICAL LABORATORIES LLC. 228
TABLE 238 NORTHEAST BIOANALYTICAL LABORATORIES LLC.: COMPANY OVERVIEW 228
12.2.6 Q2 SOLUTIONS LLC 228
TABLE 239 Q2 SOLUTIONS LLC: COMPANY OVERVIEW 228
12.2.7 JSR LIFE SCIENCES, LLC 229
TABLE 240 JSR LIFE SCIENCES, LLC: COMPANY OVERVIEW 229
12.2.8 BIOAGILYTIX LABS 229
TABLE 241 BIOAGILYTIX LABS.: COMPANY OVERVIEW 229
12.2.9 CELERION 230
TABLE 242 CELERION: COMPANY OVERVIEW 230
12.2.10 ANYGENES 230
TABLE 243 ANYGENES: COMPANY OVERVIEW 230
12.2.11 BIOMARKERBAY B. V. 231
TABLE 244 BIOMARKERBAY: COMPANY OVERVIEW 231
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
13 APPENDIX 232
13.1 DISCUSSION GUIDE 232
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 235
13.3 AVAILABLE CUSTOMIZATIONS 237
13.4 RELATED REPORTS 237
13.5 AUTHOR DETAILS 238

Acrylic Polymer Market for Cleaning Application by Type(Water-borne & Solvent-borne), Application(Laundry & Detergent, Dish Washing, Industrial & Inst...

Publisher:        MarketsandMarkets

# of Pages:        139

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
TABLE 1 PROPERTY COMPARISON OF HOMO- AND CO-POLYMER OF ACRYLIC ACID 24
1.2.1 SCOPE OF THE REPORT 24
1.3 MARKET SCOPE 25
FIGURE 1 ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION: MARKET SEGMENTATION 25
1.3.1 REGIONS COVERED 25
1.3.2 YEARS CONSIDERED FOR THE REPORT 26
1.4 CURRENCY 26
1.5 UNITS CONSIDERED 26
1.6 STAKEHOLDERS 26
1.7 LIMITATIONS 27
2 RESEARCH METHODOLOGY 28
2.1 RESEARCH DATA 28
FIGURE 2 ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION: RESEARCH DESIGN 28
2.1.1 SECONDARY DATA 28
2.1.1.1 Critical secondary inputs 29
2.1.1.2 Key data from secondary sources 29
2.1.2 PRIMARY DATA 29
2.1.2.1 Critical primary inputs 30
2.1.2.2 Key data from primary sources 30
2.1.2.3 Key industry insights 31
2.1.2.4 Breakdown of primary interviews 31
2.2 MARKET SIZE ESTIMATION APPROACH 32
2.2.1 BOTTOM-UP MARKET SIZE ESTIMATION: MARKET SIZE OF SEVERAL COUNTRIES AND ASCERTAINING THEIR SHARE TO ESTIMATE OVERALL DEMAND 32
FIGURE 3 MARKET SIZE ESTIMATION: DEMAND-SIDE ANALYSIS 32
2.3 DATA TRIANGULATION 33
FIGURE 4 ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION:
DATA TRIANGULATION 33
2.4 ASSUMPTIONS 34
3 EXECUTIVE SUMMARY 35
FIGURE 5 WATER-BORNE SEGMENT ACCOUNTED FOR LARGER MARKET SHARE IN 2020 35
FIGURE 6 LAUNDRY & DETERGENT HELD MAJOR SHARE IN OVERALL MARKET IN 2020 36
FIGURE 7 NORTH AMERICA WAS LARGEST ACRYLIC POLYMER MARKET IN 2020 36
4 PREMIUM INSIGHTS 38
4.1 SIGNIFICANT OPPORTUNITIES IN ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION 38
FIGURE 8 HIGH DEMAND FROM LAUNDRY & DETERGENT TO DRIVE MARKET BETWEEN 2021 AND 2026 38
4.2 NORTH AMERICA ACRYLIC POLYMER MARKET, BY TYPE AND COUNTRY, 2020 38
FIGURE 9 US ACCOUNTED FOR LARGEST SHARE OF MARKET IN NORTH AMERICA 38
4.3 ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY KEY COUNTRIES 39
FIGURE 10 CHINA AND INDIA TO REGISTER HIGHEST CAGR 39
5 MARKET OVERVIEW 40
5.1 INTRODUCTION 40
5.2 MARKET DYNAMICS 40
FIGURE 11 DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES IN
ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION 40
5.2.1 DRIVERS 41
5.2.1.1 Growing demand from laundry detergent market 41
FIGURE 12 GLOBAL LAUNDRY DETERGENTS MARKET SIZE (USD BILLION)
AND Y-O-Y GROWTH, 2017-2020 41
5.2.1.2 Increasing demand from industrial and institutional cleaning applications 41
TABLE 2 EUROPE CLEANING AND HYGIENE PRODUCTS DEMAND IN PROFESSIONAL SECTOR AND Y-O-Y GROWTH, 2020 42
5.2.1.3 Workplace hygiene initiatives driving demand for cleaning chemicals 42
5.2.2 RESTRAINTS 42
5.2.2.1 Fluctuating raw material prices due to volatility in crude oil prices 42
FIGURE 13 CRUDE OIL PRICES (USD/BARREL), JANUARY 2021 TO FEBRUARY 2022 43
5.2.2.2 Potential health and environmental issues of solvent-based acrylic polymers 43
5.2.3 OPPORTUNITIES 43
5.2.3.1 Growing requirement for environmentally sustainable formulations 43
5.2.4 CHALLENGES 44
5.2.4.1 Stringent regulations and restrictions 44
5.3 PORTER'S FIVE FORCES ANALYSIS 44
FIGURE 14 ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION: PORTER'S FIVE FORCES ANALYSIS 44
5.3.1 BARGAINING POWER OF SUPPLIERS 45
5.3.2 BARGAINING POWER OF BUYERS 45
5.3.3 INTENSITY OF COMPETITIVE RIVALRY 45
5.3.4 THREAT OF NEW ENTRANTS 45
5.3.5 THREAT OF SUBSTITUTES 46
TABLE 3 ACRYLIC POLYMER MARKET: PORTER'S FIVE FORCES ANALYSIS 46
5.4 SUPPLY CHAIN ANALYSIS 46
FIGURE 15 SUPPLY CHAIN OF ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION 46
5.5 PRICING ANALYSIS 47
FIGURE 16 PRICING ANALYSIS (USD/TON) OF ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY REGION (2020) 47
FIGURE 17 FORECASTING FACTOR AND IMPACT ANALYSIS 48
5.6 MICROPLASTIC 49
5.6.1 SOURCES OF MICROPLASTICS 49
5.6.1.1 Textiles 49
5.6.1.2 Road transport 49
5.6.1.3 Marine coatings and fishing industry 49
5.6.1.4 Personal care products 49
5.6.2 IMPACT OF MICROPLASTICS ON MARINE, LAND, AND CLIMATE 50
5.6.2.1 Impact on marine 50
5.6.2.2 Impact on land 50
5.6.2.3 Impact on climate 50
5.6.2.4 Impacts on human health 50
5.7 PATENT ANALYSIS 51
5.7.1 METHODOLOGY 51
5.7.2 DOCUMENT TYPE 51
TABLE 4 ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION: GRANTED, APPLIED, AND LIMITED PATENTS 51
FIGURE 18 PATENT PUBLICATION TRENDS - LAST 10 YEARS 52
5.7.3 INSIGHT 52
5.7.4 LEGAL STATUS OF PATENTS 53
FIGURE 19 ACRYLIC POLYMER PATENTS: LEGAL STATUS (2011-2021) 53
5.7.5 JURISDICTION ANALYSIS 53
FIGURE 20 TOP JURISDICTION, BY COUNTRY 53
5.7.6 TOP COMPANIES/APPLICANTS 54
FIGURE 21 TOP 10 COMPANIES/APPLICANTS WITH HIGHEST NUMBER OF PATENTS 54
TABLE 5 LIST OF PATENTS FOR ACRYLIC POLYMER IN CLEANING APPLICATION 54
6 ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY TYPE 56
6.1 INTRODUCTION 57
FIGURE 22 WATER-BORNE ACRYLIC POLYMER TO BE FASTER-GROWING SEGMENT DURING FORECAST PERIOD 57
TABLE 6 ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION BY TYPE,
2019–2026 (TON) 57
TABLE 7 ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY TYPE,
2019–2026 (USD MILLION) 57
6.2 WATER-BORNE 58
6.2.1 DEMAND FROM HOUSEHOLD CLEANING PRODUCTS TO DRIVE WATER-BORNE ACRYLIC POLYMERS MARKET 58
TABLE 8 WATER-BORNE: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY REGION, 2019–2026 (TON) 58
TABLE 9 WATER-BORNE: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY REGION, 2019–2026 (USD MILLION) 58
6.3 SOLVENT-BORNE 59
6.3.1 GROWING DEMAND FOR SUSTAINABLE PRODUCTS TO RESTRICT GROWTH OF MARKET 59
TABLE 10 SOLVENT-BORNE: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY REGION, 2019–2026 (TON) 59
TABLE 11 SOLVENT-BORNE: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY REGION, 2019–2026 (USD MILLION) 59
7 ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY APPLICATION 60
7.1 INTRODUCTION 61
FIGURE 23 LAUNDRY & DETERGENT TO DOMINATE OVERALL MARKET DURING FORECAST PERIOD 61
TABLE 12 ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY APPLICATION, 2019–2026 (TON) 61
TABLE 13 ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY APPLICATION, 2019–2026 (USD MILLION) 62
7.2 LAUNDRY & DETERGENT 62
7.2.1 RISE IN DEMAND FOR HIGH-PERFORMANCE LAUNDRY & DETERGENT TO DRIVE MARKET 62
TABLE 14 LAUNDRY & DETERGENT: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY REGION, 2019–2026 (TON) 62
TABLE 15 LAUNDRY & DETERGENT: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY REGION, 2019–2026 (USD MILLION) 63
7.3 DISH WASHING 63
7.3.1 INCREASING USAGES OF DISHWASHING PRODUCTS IN HOMECARE, FOOD SERVICE CENTERS, AND HOTEL INDUSTRY TO DRIVE MARKET 63
TABLE 16 DISH WASHING: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY REGION, 2019–2026 (TON) 63
TABLE 17 DISH WASHING: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY REGION, 2019–2026 (USD MILLION) 64
7.4 INDUSTRIAL & INSTITUTIONAL 64
7.4.1 STRONG EMPHASIS ON HYGIENE IN INDUSTRIAL AND INSTITUTIONAL PLACES TO SUPPORT MARKET GROWTH 64
TABLE 18 USES OF CLEANING APPLICATIONS IN SEVERAL INDUSTRIES 64
TABLE 19 INDUSTRIAL & INSTITUTIONAL: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY REGION, 2019–2026 (TON) 65
TABLE 20 INDUSTRIAL & INSTITUTIONAL: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY REGION, 2019–2026 (USD MILLION) 65
7.5 HARD SURFACE CLEANING 65
7.5.1 HIGH PREVALENCE OF INFECTIONS TO DRIVE USE OF HARD SURFACE CLEANING PRODUCTS IN SEVERAL SECTORS 65
TABLE 21 HARD SURFACE CLEANING: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY REGION, 2019–2026 (TON) 66
TABLE 22 HARD SURFACE CLEANING: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY REGION, 2019–2026 (USD MILLION) 66
7.6 OTHERS 66
TABLE 23 OTHERS: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY REGION, 2019–2026 (TON) 66
TABLE 24 OTHERS: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY REGION, 2019–2026 (USD MILLION) 67
8 ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY REGION 68
8.1 INTRODUCTION 69
FIGURE 24 REGIONAL SNAPSHOT: ASIA PACIFIC EMERGING AS NEW HOTSPOT 69
TABLE 25 ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY REGION, 2019–2026 (TON) 69
TABLE 26 ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY REGION, 2019–2026 (USD MILLION) 70
8.2 NORTH AMERICA 70
FIGURE 25 NORTH AMERICA: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION SNAPSHOT 71
TABLE 27 NORTH AMERICA: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY COUNTRY, 2019–2026 (TON) 71
TABLE 28 NORTH AMERICA: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY COUNTRY, 2019–2026 (USD MILLION) 72
TABLE 29 NORTH AMERICA: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY TYPE, 2019–2026 (TON) 72
TABLE 30 NORTH AMERICA: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY TYPE, 2019–2026 (USD MILLION) 72
TABLE 31 NORTH AMERICA: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY APPLICATION, 2019–2026 (TON) 72
TABLE 32 NORTH AMERICA: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY APPLICATION, 2019–2026 (USD MILLION) 73
8.2.1 US 73
8.2.1.1 Increasing consumer awareness for cleaning products to drive market 73
TABLE 33 US: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (TON) 73
TABLE 34 US: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (USD MILLION) 74
8.2.2 CANADA 74
8.2.2.1 Rise in cleaning activities to positively influence market 74
TABLE 35 CANADA: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (TON) 74
TABLE 36 CANADA: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (USD MILLION) 75
8.2.3 MEXICO 75
8.2.3.1 Increasing health & hygiene concerns to boost demand for cleaning products 75
TABLE 37 MEXICO: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (TON) 75
TABLE 38 MEXICO: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (USD MILLION) 76
 
8.3 EUROPE 76
FIGURE 26 EUROPE: ACRYLIC POLYMER MARKET SNAPSHOT 77
TABLE 39 EUROPE: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY COUNTRY, 2019–2026 (TON) 78
TABLE 40 EUROPE: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY COUNTRY, 2019–2026 (USD MILLION) 78
TABLE 41 EUROPE: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY TYPE, 2019–2026 (TON) 78
TABLE 42 EUROPE: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY TYPE, 2019–2026 (USD MILLION) 79
TABLE 43 EUROPE: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (TON) 79
TABLE 44 EUROPE: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (USD MILLION) 79
8.3.1 GERMANY 79
8.3.1.1 Expansion of healthcare & hygiene sector creates favorable conditions for market growth 79
TABLE 45 GERMANY: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (TON) 80
TABLE 46 GERMANY: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (USD MILLION) 80
8.3.2 FRANCE 80
8.3.2.1 Rising demand for cleaning and washing products to increase demand for acrylic polymer 80
TABLE 47 FRANCE: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (TON) 81
TABLE 48 FRANCE: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (USD MILLION) 81
8.3.3 UK 81
8.3.3.1 Rise in spending on health and hygiene to drive UK acrylic polymer market 81
TABLE 49 UK: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (TON) 82
TABLE 50 UK: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (USD MILLION) 82
8.3.4 ITALY 82
8.3.4.1 Increasing industrial and institutional cleaning to drive market 82
TABLE 51 ITALY: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (TON) 83
TABLE 52 ITALY: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (USD MILLION) 83
8.3.5 SPAIN 83
8.3.5.1 Growth in laundry & detergent application to drive market 83
TABLE 53 SPAIN: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (TON) 84
TABLE 54 SPAIN: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (USD MILLION) 84
 
8.3.6 RUSSIA 84
8.3.6.1 Increasing investment in cleaning products to drive market 84
TABLE 55 RUSSIA: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (TON) 85
TABLE 56 RUSSIA: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (USD MILLION) 85
8.3.7 BENELUX 85
8.3.7.1 Increasing exports and imports of acrylic polymer to drive market 85
TABLE 57 BENELUX: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (TON) 86
TABLE 58 BENELUX: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (USD MILLION) 86
8.3.8 NORDIC COUNTRIES 86
8.3.8.1 Steady growth in demand for cleaning products to drive the market 86
TABLE 59 NORDIC COUNTRIES: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY APPLICATION, 2019–2026 (TON) 87
TABLE 60 NORDIC COUNTRIES: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY APPLICATION, 2019–2026 (USD MILLION) 87
8.3.9 REST OF EUROPE 87
TABLE 61 REST OF EUROPE: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY APPLICATION, 2019–2026 (TON) 87
TABLE 62 REST OF EUROPE: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY APPLICATION, 2019–2026 (USD MILLION) 88
8.4 ASIA PACIFIC 88
FIGURE 27 ASIA PACIFIC: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION SNAPSHOT 89
TABLE 63 ASIA PACIFIC: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY COUNTRY, 2019–2026 (TON) 89
TABLE 64 ASIA PACIFIC: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY COUNTRY, 2019–2026 (USD MILLION) 90
TABLE 65 ASIA PACIFIC: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY TYPE, 2019–2026 (TON) 90
TABLE 66 ASIA PACIFIC: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY TYPE, 2019–2026 (USD MILLION) 90
TABLE 67 ASIA PACIFIC: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (TON) 90
TABLE 68 ASIA PACIFIC: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (USD MILLION) 91
8.4.1 CHINA 91
8.4.1.1 Healthy growth of cleaning industry is major driver of acrylic polymer market 91
TABLE 69 CHINA: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (TON) 91
TABLE 70 CHINA: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (USD MILLION) 92
 
8.4.2 JAPAN 92
8.4.2.1 Strong cleaning standards and regulations in country to drive market 92
TABLE 71 JAPAN SOAP, SYNTHETIC DETERGENTS, AND SURFACE­ACTIVE AGENTS PRODUCTION, 2020 (TON) 92
TABLE 72 JAPAN: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (TON) 93
TABLE 73 JAPAN: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (USD MILLION) 93
8.4.3 INDIA 93
8.4.3.1 Growing awareness pertaining to hygiene and cleaning coupled with changing lifestyle supporting market growth 93
TABLE 74 INDIA: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (TON) 94
TABLE 75 INDIA: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (USD MILLION) 94
8.4.4 SOUTH KOREA 94
8.4.4.1 Personal and household care products will support growth of acrylic polymer market 94
TABLE 76 SOUTH KOREA: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (TON) 95
TABLE 77 SOUTH KOREA: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (USD MILLION) 95
8.4.5 ASEAN COUNTRIES 95
8.4.5.1 Rising health & hygiene concerns to boost market 95
TABLE 78 ASEAN COUNTRIES: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY APPLICATION, 2019–2026 (TON) 96
TABLE 79 ASEAN COUNTRIES: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY APPLICATION, 2019–2026 (USD MILLION) 96
8.4.6 REST OF ASIA PACIFIC 96
TABLE 80 REST OF ASIA PACIFIC: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY APPLICATION, 2019–2026 (TON) 96
TABLE 81 REST OF ASIA PACIFIC: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY APPLICATION, 2019–2026 (USD MILLION) 97
8.5 REST OF WORLD 97
TABLE 82 REST OF WORLD: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY COUNTRY, 2019–2026 (TON) 97
TABLE 83 REST OF WORLD: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY COUNTRY, 2019–2026 (USD MILLION) 98
TABLE 84 REST OF WORLD: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY TYPE, 2019–2026 (TON) 98
TABLE 85 REST OF WORLD: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY TYPE, 2019–2026 (USD MILLION) 98
TABLE 86 REST OF WORLD: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY APPLICATION, 2019–2026 (TON) 98
TABLE 87 REST OF WORLD: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION, BY APPLICATION, 2019–2026 (USD MILLION) 99
 
8.5.1 SAUDI ARABIA 99
8.5.1.1 Increasing demand for detergents & industrial cleaning products to drive growth of acrylic polymer market 99
TABLE 88 SAUDI ARABIA: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (TON) 99
TABLE 89 SAUDI ARABIA: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (USD MILLION) 100
8.5.2 UAE 100
8.5.2.1 Rapid urbanization expected to propel growth of UAE market 100
TABLE 90 UAE: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (TON) 100
TABLE 91 UAE: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (USD MILLION) 101
8.5.3 BRAZIL 101
8.5.3.1 Brazil is one of largest markets for acrylic polymer in cleaning application in Rest of World 101
TABLE 92 BRAZIL: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (TON) 101
TABLE 93 BRAZIL: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (USD MILLION) 102
8.5.4 SOUTH AFRICA 102
8.5.4.1 Growth in consumer awareness regarding cleaning & personal hygiene products 102
TABLE 94 SOUTH AFRICA: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (TON) 102
TABLE 95 SOUTH AFRICA: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (USD MILLION) 103
8.5.5 OTHERS 103
TABLE 96 OTHERS: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (TON) 103
TABLE 97 OTHERS: ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION,
BY APPLICATION, 2019–2026 (USD MILLION) 103
9 COMPETITIVE LANDSCAPE 104
9.1 INTRODUCTION 104
FIGURE 28 COMPANIES MAINLY ADOPTED INORGANIC GROWTH STRATEGIES BETWEEN 2018 AND 2021 104
9.2 MARKET SHARE ANALYSIS 105
FIGURE 29 MARKET SHARE OF KEY PLAYERS, 2020 105
TABLE 98 ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION: DEGREE OF COMPETITION 105
TABLE 99 STRATEGIC POSITIONING OF KEY PLAYERS 106
9.3 COMPETITIVE SITUATION & TRENDS 107
9.3.1 EXPANSIONS 107
TABLE 100 EXPANSIONS, 2018-2021 107
9.3.2 DEALS 108
TABLE 101 DEALS, 2018–2021 108
10 COMPANY PROFILE 109
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
10.1 KEY PLAYERS 109
10.1.1 DOW INC. 109
TABLE 102 DOW INC.: COMPANY OVERVIEW 109
FIGURE 30 DOW INC.: COMPANY SNAPSHOT 110
FIGURE 31 DOW'S CAPABILITY IN ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION 111
10.1.2 BASF SE 112
TABLE 103 BASF SE: BUSINESS OVERVIEW 112
FIGURE 32 BASF SE: COMPANY SNAPSHOT 113
TABLE 104 BASF SE.: DEALS 114
FIGURE 33 BASF'S CAPABILITY IN ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION 116
10.1.3 TOAGOSEI CO., LTD. 117
TABLE 105 TOAGOSEI CO., LTD.: COMPANY OVERVIEW 117
FIGURE 34 TOAGOSEI CO., LTD: COMPANY SNAPSHOT 117
FIGURE 35 TOAGOSEI'S CAPABILITIES IN ACRYLIC
POLYMER MARKET FOR CLEANING APPLICATION 119
10.1.4 SUMITOMO SEIKA CHEMICALS CO., LTD. 120
TABLE 106 SUMITOMO SEIKA CHEMICALS CO., LTD.: BUSINESS OVERVIEW 120
FIGURE 36 SUMITOMO SEIKA CHEMICALS CO., LTD.: COMPANY SNAPSHOT 120
TABLE 107 SUMITOMO SEIKA CHEMICALS CO. LTD.:
PRODUCT/SOLUTION/SERVICE OFFERED 121
10.1.5 ARKEMA 122
TABLE 108 ARKEMA: BUSINESS OVERVIEW 122
FIGURE 37 ARKEMA: COMPANY SNAPSHOT 122
FIGURE 38 ARKEMA'S CAPABILITY IN ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION 124
10.1.6 NIPPON SHOKUBAI CO. LTD. 125
TABLE 109 NIPPON SHOKUBAI CO.LTD.: BUSINESS OVERVIEW 125
FIGURE 39 NIPPON SHOKUBAI: COMPANY SNAPSHOT 125
TABLE 110 NIPPON SHOKUBAI CO. LTD.: DEALS 126
FIGURE 40 NIPPON SHOKUBAI'S CAPABILITIES IN ACRYLIC POLYMER MARKET FOR CLEANING APPLICATION 127
10.1.7 ASHLAND GLOBAL HOLDINGS, INC. 128
TABLE 111 ASHLAND GLOBAL HOLDINGS, INC.: BUSINESS OVERVIEW 128
FIGURE 41 ASHLAND GLOBAL HOLDINGS, INC: COMPANY SNAPSHOT 128
TABLE 112 ASHLAND GLOBAL HOLDINGS, INC.:
PRODUCT/SOLUTION/SERVICE OFFERED 129
TABLE 113 ASHLAND GLOBAL HOLDINGS, INC.: DEALS 129
10.2 OTHER KEY PLAYERS 131
10.2.1 THE LUBRIZOL CORPORATION 131
TABLE 114 THE LUBRIZOL CORPORATION: BUSINESS OVERVIEW 131
10.2.2 CHEMIPOL, S.A. 131
TABLE 115 CHEMIPOL, S.A.: BUSINESS OVERVIEW 131
10.2.3 ANSHIKA POLYSURF LIMITED 132
TABLE 116 ANSHIKA POLYSURF LIMITED: COMPANY OVERVIEW 132
10.2.4 MCTRON 132
TABLE 117 MCTRON: COMPANY OVERVIEW 132
10.2.5 WEIFANG RUIGUANG CHEMICAL 133
TABLE 118 WEIFANG RUIGUANG CHEMICAL: COMPANY OVERVIEW 133
10.2.6 PIKA INDIA TECHNOLOGIES 133
TABLE 119 PIKA INDIA TECHNOLOGIES: COMPANY OVERVIEW 133
10.2.7 NOURYON 134
TABLE 120 NOURYON: COMPANY OVERVIEW 134
10.2.8 GELLNER INDUSTRIAL 134
TABLE 121 GELLNER INDUSTRIAL: COMPANY OVERVIEW 134
10.2.9 GROUPE PROTEX INTERNATIONAL 135
TABLE 122 GROUPE PROTEX INTERNATIONAL: COMPANY OVERVIEW 135
10.2.10 ANHUI NEWMAN FINE CHEMICALS CO., LTD. 135
TABLE 123 ANHUI NEWMAN FINE CHEMICALS CO., LTD.: COMPANY OVERVIEW 135
10.2.11 MAXWELL ADDITIVES PRIVATE LIMITED 136
TABLE 124 MAXWELL ADDITIVES PRIVATE LIMITED: COMPANY OVERVIEW 136
10.2.12 SOLVAY SA 136
TABLE 125 SOLVAY: COMPANY OVERVIEW 136
10.2.13 SHANGHAI BAOLIJIA CHEMICAL LIMITED 137
TABLE 126 SHANGHAI BAOLIJIA CHEMICAL LIMITED: COMPANY OVERVIEW 137
10.2.14 KAMSONS CHEMICALS PVT. LTD. 137
TABLE 127 KAMSONS CHEMICALS PVT. LTD.: COMPANY OVERVIEW 137
10.2.15 STI POLYMER 138
TABLE 128 STI POLYMER: COMPANY OVERVIEW 138
10.2.16 MICHELMAN 138
TABLE 129 MICHELMAN: COMPANY OVERVIEW 138
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
11 APPENDIX 139
11.1 DISCUSSION GUIDE 139
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 141
11.3 AVAILABLE CUSTOMIZATIONS 143
11.4 RELATED REPORTS 143
11.5 AUTHOR DETAILS 144

Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRN...

Publisher:        MarketsandMarkets

# of Pages:        239

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 30
1.1 OBJECTIVES OF THE STUDY 30
1.2 MARKET DEFINITION 30
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 31
1.3 MARKET SCOPE 32
1.3.1 MARKETS COVERED 32
FIGURE 1 METAGENOMIC SEQUENCING MARKET SEGMENTATION 32
1.3.2 YEARS CONSIDERED FOR THE STUDY 33
1.4 CURRENCY 33
1.5 LIMITATIONS 33
1.6 STAKEHOLDERS 34
1.7 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 2 RESEARCH DESIGN 35
2.1.1 SECONDARY DATA 36
2.1.2 PRIMARY DATA 37
FIGURE 3 PRIMARY SOURCES 37
FIGURE 4 METAGENOMIC SEQUENCING MARKET: BREAKDOWN OF PRIMARIES 38
2.1.2.1 Key industry insights 39
2.2 MARKET SIZE ESTIMATION 39
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2021 39
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP (SUPPLY SIDE) – COLLECTIVE REVENUE OF ALL METAGENOMIC SEQUENCING
PRODUCTS & SERVICES 40
FIGURE 7 METAGENOMIC SEQUENCING MARKET: CAGR PROJECTIONS, 2022–2027 42
FIGURE 8 METAGENOMIC SEQUENCING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 42
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 44
FIGURE 9 DATA TRIANGULATION METHODOLOGY 44
2.4 RESEARCH LIMITATIONS 45
2.5 GROWTH RATE ASSUMPTIONS 45
2.6 RISK ANALYSIS 45
 
3 EXECUTIVE SUMMARY 46
FIGURE 10 METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE,
2022 VS. 2027 (USD MILLION) 46
FIGURE 11 METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021 47
FIGURE 12 METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 48
FIGURE 13 METAGENOMIC SEQUENCING MARKET SHARE, BY TECHNOLOGY, 2021 49
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF THE METAGENOMIC SEQUENCING MARKET 50
4 PREMIUM INSIGHTS 51
4.1 METAGENOMIC SEQUENCING MARKET OVERVIEW 51
FIGURE 15 TECHNOLOGICAL INNOVATIONS IN NGS PLATFORMS—A KEY FACTOR DRIVING GROWTH IN THE METAGENOMIC SEQUENCING MARKET 51
4.2 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY
& COUNTRY (2021) 52
FIGURE 16 16S RRNA SEQUENCING TECHNOLOGY ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 52
4.3 METAGENOMIC SEQUENCING MARKET SHARE FOR INDUSTRIAL APPLICATIONS,
BY TYPE, 2021 53
FIGURE 17 ENERGY APPLICATION SEGMENT DOMINATED THE MARKET IN 2021 53
5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS 54
FIGURE 18 METAGENOMIC SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54
5.2.1 DRIVERS 55
5.2.1.1 Continuous technological innovations in NGS platforms 55
5.2.1.1.1 iSeq 100 System 55
5.2.1.1.2 Ion GeneStudio S5 55
5.2.1.2 Initiatives and funding from government & private bodies for large-scale sequencing projects 55
TABLE 1 GLOBAL SEQUENCING INITIATIVES 56
5.2.1.3 Declining costs of genome sequencing 57
FIGURE 19 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001–2020 57
5.2.1.4 Significant applications of metagenomics in various fields 57
5.2.2 RESTRAINTS 58
5.2.2.1 End-user budget constraints in developing countries 58
5.2.3 OPPORTUNITIES 59
5.2.3.1 NGS data analysis using big data 59
FIGURE 20 DATA PRODUCTION DURING HUMAN WHOLE-GENOME SEQUENCING,
2001–2019 59
5.2.4 CHALLENGES 60
5.2.4.1 Challenges associated with metagenomic NGS 60
5.3 IMPACT OF COVID-19 ON THE METAGENOMIC SEQUENCING MARKET 61
5.4 PORTER’S FIVE FORCES ANALYSIS 63
TABLE 2 METAGENOMIC SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS 63
5.4.1 THREAT OF NEW ENTRANTS 63
5.4.2 THREAT OF SUBSTITUTES 63
5.4.3 BARGAINING POWER OF SUPPLIERS 63
5.4.4 BARGAINING POWER OF BUYERS 63
5.4.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS 64
5.5 VALUE CHAIN ANALYSIS 64
FIGURE 21 VALUE CHAIN ANALYSIS OF THE METAGENOMIC SEQUENCING MARKET: MANUFACTURING AND ASSEMBLY PHASES ADD MAXIMUM VALUE 64
FIGURE 22 VALUE CHAIN: METAGENOMIC SEQUENCING ANALYSIS WORKFLOW —MAXIMUM VALUE IS ADDED DURING THE SEQUENCING AND
ANALYSIS PHASES 65
5.6 ECOSYSTEM ANALYSIS 66
FIGURE 23 ECOSYSTEM ANALYSIS: METAGENOMIC SEQUENCING MARKET 66
TABLE 3 SUPPLY CHAIN ECOSYSTEM 66
5.7 PATENT ANALYSIS 67
5.7.1 TOP 10 GRANTED PATENT OWNERS IN THE LAST 20 YEARS 67
5.7.2 TOP 10 PLAYERS WITH THE HIGHEST NO. OF PATENT APPLICATIONS 68
5.7.3 LIST OF RECENT PATENTS 68
5.8 SUPPLY CHAIN ANALYSIS 69
FIGURE 24 DIRECT DISTRIBUTION—THE PREFERRED STRATEGY FOR PROMINENT COMPANIES 70
5.9 REGULATORY ANALYSIS 70
5.9.1 NORTH AMERICA 70
5.9.1.1 US 70
TABLE 4 US FDA: MEDICAL DEVICE CLASSIFICATION 71
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 71
5.9.1.2 Canada 72
5.9.2 EUROPE 72
5.9.3 ASIA PACIFIC 73
5.9.3.1 China 73
TABLE 6 CHINA: CLASSIFICATION OF MEDICAL DEVICES 73
5.9.3.2 Japan 73
5.9.3.3 India 73
5.9.4 LATIN AMERICA 74
5.9.5 MIDDLE EAST 74
5.10 PRICING ANALYSIS 74
TABLE 7 AVERAGE SELLING PRICE OF NGS SYSTEMS (2020) 74
5.11 RANGES/SCENARIOS 75
FIGURE 25 DEPENDING ON HOW THE UNCERTAINTIES UNFOLD, WE SEE A SPECTRUM OF SCENARIOS FOR THE METAGENOMIC SEQUENCING MARKET 75
5.12 TRADE ANALYSIS 75
5.12.1 TRADE ANALYSIS FOR METAGENOMIC SEQUENCING MARKET 75
TABLE 8 IMPORT DATA FOR HS CODE 902780, BY COUNTRY,
2016-2020 (USD THOUSAND) 75
TABLE 9 EXPORT DATA FOR HS CODE 902780, BY COUNTRY,
2016-2020 (USD THOUSAND) 76
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 76
5.14 KEY CONFERENCES & EVENTS, 2022 77
TABLE 10 METAGENOMIC SEQUENCING MARKET: DETAILED LIST OF CONFERENCES & EVENTS 77
5.15 KEY STAKEHOLDERS & BUYING CRITERIA 78
TABLE 11 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP THREE APPLICATIONS (%) 78
TABLE 12 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 78
6 METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE 79
6.1 INTRODUCTION 80
TABLE 13 METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION) 80
6.2 REAGENTS & CONSUMABLES 80
6.2.1 RISING ADOPTION OF METAGENOMIC SEQUENCING IS DRIVING
THE USE OF REAGENTS & CONSUMABLES 80
TABLE 14 METAGENOMIC SEQUENCING REAGENTS & CONSUMABLES MARKET,
BY REGION, 2020–2027 (USD MILLION) 81
TABLE 15 NORTH AMERICA: METAGENOMIC SEQUENCING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 81
TABLE 16 EUROPE: METAGENOMIC SEQUENCING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 81
TABLE 17 APAC: METAGENOMIC SEQUENCING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3 INSTRUMENTS 82
6.3.1 LAUNCH OF ADVANCED NGS PLATFORMS WILL SUPPORT
THE GROWTH OF THIS SEGMENT 82
TABLE 18 METAGENOMIC SEQUENCING INSTRUMENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 83
TABLE 19 NORTH AMERICA: METAGENOMIC SEQUENCING INSTRUMENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 83
TABLE 20 EUROPE: METAGENOMIC SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 83
TABLE 21 APAC: METAGENOMIC SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 SERVICES 84
6.4.1 TIME AND COST-EFFECTIVENESS OF OUTSOURCING NGS PROJECTS HAS DRIVEN THE DEMAND FOR SERVICES 84
TABLE 22 METAGENOMIC SEQUENCING SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 84
TABLE 23 NORTH AMERICA: METAGENOMIC SEQUENCING SERVICES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 85
TABLE 24 EUROPE: METAGENOMIC SEQUENCING SERVICES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 85
TABLE 25 APAC: METAGENOMIC SEQUENCING SERVICES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 85
6.5 ANALYSIS & DATA INTERPRETATION SOLUTIONS 86
6.5.1 LIMITED TECHNICAL KNOWLEDGE OF ADVANCED ANALYSIS SOLUTIONS AMONG END USERS TO HAMPER MARKET GROWTH 86
TABLE 26 METAGENOMIC SEQUENCING ANALYSIS & DATA INTERPRETATION SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 86
TABLE 27 NORTH AMERICA: METAGENOMIC SEQUENCING ANALYSIS & DATA INTERPRETATION SOLUTIONS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 86
TABLE 28 EUROPE: METAGENOMIC SEQUENCING ANALYSIS & DATA INTERPRETATION SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87
TABLE 29 APAC: METAGENOMIC SEQUENCING ANALYSIS & DATA INTERPRETATION SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87
7 METAGENOMIC SEQUENCING MARKET, BY WORKFLOW 88
7.1 INTRODUCTION 89
TABLE 30 METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION) 89
7.2 SAMPLE PROCESSING & LIBRARY PREPARATION 89
7.2.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED SAMPLE PROCESSING AND LIBRARY PREPARATION ASSAY KITS IS DRIVING MARKET GROWTH 89
TABLE 31 SAMPLE PROCESSING & LIBRARY PREPARATION MARKET, BY REGION, 2020–2027 (USD MILLION) 90
TABLE 32 NORTH AMERICA: SAMPLE PROCESSING & LIBRARY PREPARATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 90
TABLE 33 EUROPE: SAMPLE PROCESSING & LIBRARY PREPARATION MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 91
TABLE 34 APAC: SAMPLE PROCESSING & LIBRARY PREPARATION MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 91
7.3 SEQUENCING 91
7.3.1 SANGER SEQUENCING HAS BEEN SUPPLANTED BY NGS DUE TO ITS ADVANTAGES AND RAPIDITY 91
TABLE 35 SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 92
TABLE 36 NORTH AMERICA: SEQUENCING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 92
TABLE 37 EUROPE: SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 92
TABLE 38 APAC: SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.4 DATA PROCESSING & ANALYSIS 93
7.4.1 NEED FOR SKILLED PERSONNEL TO OPERATE DATA PROCESSING AND ANALYTICS TOOLS HAS SLOWED MARKET GROWTH 93
TABLE 39 DATA PROCESSING & ANALYSIS MARKET, BY REGION,
2020–2027 (USD MILLION) 94
TABLE 40 NORTH AMERICA: DATA PROCESSING & ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 94
TABLE 41 EUROPE: DATA PROCESSING & ANALYSIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 94
TABLE 42 APAC: DATA PROCESSING & ANALYSIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 95
8 METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY 96
8.1 INTRODUCTION 97
TABLE 43 METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 97
8.2 16S RRNA SEQUENCING 97
8.2.1 16S RRNA SEQUENCING IS A COST-EFFECTIVE TECHNIQUE FOR THE IDENTIFICATION OF BACTERIAL STRAINS 97
TABLE 44 16S RRNA SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 98
TABLE 45 NORTH AMERICA: 16S RRNA SEQUENCING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 98
TABLE 46 EUROPE: 16S RRNA SEQUENCING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 99
TABLE 47 APAC: 16S RRNA SEQUENCING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 99
8.3 SHOTGUN METAGENOMIC SEQUENCING 99
8.3.1 SHOTGUN METAGENOMIC SEQUENCING SEGMENT TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 99
TABLE 48 SHOTGUN METAGENOMIC SEQUENCING MARKET, BY REGION,
2020–2027 (USD MILLION) 100
TABLE 49 NORTH AMERICA: SHOTGUN METAGENOMIC SEQUENCING MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 100
TABLE 50 EUROPE: SHOTGUN METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 101
TABLE 51 APAC: SHOTGUN METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 101
8.4 WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY 101
8.4.1 WGS HELPS GENERATE ACCURATE REFERENCE GENOMES FOR MICROBIAL IDENTIFICATION 101
TABLE 52 WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET, BY REGION, 2020–2027 (USD MILLION) 102
TABLE 53 NORTH AMERICA: WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 102
TABLE 54 EUROPE: WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 103
TABLE 55 APAC: WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 103
8.5 METATRANSCRIPTOMICS 103
8.5.1 METATRANSCRIPTOMICS HELPS IN THE UNDERSTANDING OF THE ACTIVE FUNCTIONAL PROFILE OF A MICROBIAL COMMUNITY 103
TABLE 56 METATRANSCRIPTOMICS MARKET, BY REGION, 2020–2027 (USD MILLION) 104
TABLE 57 NORTH AMERICA: METATRANSCRIPTOMICS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 105
TABLE 58 EUROPE: METATRANSCRIPTOMICS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 105
TABLE 59 APAC: METATRANSCRIPTOMICS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 105
9 METAGENOMIC SEQUENCING MARKET, BY APPLICATION 106
9.1 INTRODUCTION 107
TABLE 60 METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 107
9.2 DRUG DISCOVERY 107
9.2.1 DRUG DISCOVERY ACCOUNTS FOR THE LARGEST SHARE OF THE METAGENOMIC SEQUENCING MARKET 107
TABLE 61 METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY, BY REGION, 2020–2027 (USD MILLION) 108
TABLE 62 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2020–2027 (USD MILLION) 108
TABLE 63 EUROPE: METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY,
BY COUNTRY, 2020–2027 (USD MILLION) 108
TABLE 64 APAC: METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY,
BY COUNTRY, 2020–2027 (USD MILLION) 109
9.3 CLINICAL DIAGNOSTICS 109
9.3.1 ADVANTAGES OF METAGENOMIC NGS HAVE ENABLED WIDE APPLICATIONS IN DIAGNOSTICS 109
TABLE 65 METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTICS,
BY REGION, 2020–2027 (USD MILLION) 110
TABLE 66 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 110
TABLE 67 EUROPE: METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 110
TABLE 68 APAC: METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 111
9.4 SOIL MICROBIOME APPLICATIONS 111
9.4.1 NORTH AMERICA SHOWS HIGH DEMAND FOR METAGENOMIC SEQUENCING IN SOIL MICROBIOME APPLICATIONS 111
TABLE 69 METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 111
TABLE 70 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 71 EUROPE: METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 72 APAC: METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 112
 
9.5 INDUSTRIAL APPLICATIONS 113
TABLE 73 METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS,
BY REGION, 2020–2027 (USD MILLION) 113
TABLE 74 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 113
TABLE 75 EUROPE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 114
TABLE 76 APAC: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 114
TABLE 77 METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS,
BY TYPE, 2020–2027 (USD MILLION) 114
9.5.1 ENERGY 115
9.5.1.1 Declining fossil fuel reserves and growing energy needs will drive market growth 115
TABLE 78 METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS,
BY REGION, 2020–2027 (USD MILLION) 115
TABLE 79 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 115
TABLE 80 EUROPE: METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 116
TABLE 81 APAC: METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 116
9.5.2 BIOREMEDIATION 116
9.5.2.1 Need to monitor pollutant impact and contamination will provide opportunities for metagenomic sequencing in bioremediation 116
TABLE 82 METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION, BY REGION, 2020–2027 (USD MILLION) 117
TABLE 83 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION, BY COUNTRY, 2020–2027 (USD MILLION) 117
TABLE 84 EUROPE: METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION,
BY COUNTRY, 2020–2027 (USD MILLION) 117
TABLE 85 APAC: METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION,
BY COUNTRY, 2020–2027 (USD MILLION) 118
9.5.3 OTHER INDUSTRIAL APPLICATIONS 118
TABLE 86 METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 118
TABLE 87 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 119
TABLE 88 EUROPE: METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 119
TABLE 89 APAC: METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 119
9.6 ECOLOGICAL & ENVIRONMENTAL APPLICATIONS 120
9.6.1 METAGENOMIC SEQUENCING CAN HELP IDENTIFY INVASIVE AND ENDANGERED SPECIES 120
TABLE 90 METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 120
TABLE 91 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 120
TABLE 92 EUROPE: METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 121
TABLE 93 APAC: METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 121
9.7 VETERINARY APPLICATIONS 121
9.7.1 DEMAND FOR RAPID AND ACCURATE PATHOGEN DIAGNOSIS IS SUPPORTING THE DEMAND FOR SEQUENCING 121
TABLE 94 METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS,
BY REGION, 2020–2027 (USD MILLION) 122
TABLE 95 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 122
TABLE 96 EUROPE: METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 122
TABLE 97 APAC: METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 123
9.8 OTHER APPLICATIONS 123
TABLE 98 METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS,
BY REGION, 2020–2027 (USD MILLION) 123
TABLE 99 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 124
TABLE 100 EUROPE: METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 124
TABLE 101 APAC: METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 124
10 METAGENOMIC SEQUENCING MARKET, BY REGION 125
10.1 INTRODUCTION 126
TABLE 102 METAGENOMIC SEQUENCING MARKET, BY REGION,
2020–2027 (USD MILLION) 126
10.2 NORTH AMERICA 126
FIGURE 26 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET SNAPSHOT 127
TABLE 103 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 128
TABLE 104 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2020–2027 (USD MILLION) 128
TABLE 105 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 128
TABLE 106 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 129
TABLE 107 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 129
TABLE 108 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 130
10.2.1 US 130
10.2.1.1 Well-established infrastructure and funding sources available for NGS-based small- and medium-sized research projects make the US the largest market in North America 130
TABLE 109 US: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION) 131
TABLE 110 US: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION) 131
TABLE 111 US: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 132
TABLE 112 US: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 132
TABLE 113 US: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
10.2.2 CANADA 133
10.2.2.1 Increasing government initiatives and workshops to support growth in this market 133
TABLE 114 CANADA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION) 133
TABLE 115 CANADA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 134
TABLE 116 CANADA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 134
TABLE 117 CANADA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 118 CANADA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 135
10.3 EUROPE 135
TABLE 119 EUROPE: METAGENOMIC SEQUENCING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 136
TABLE 120 EUROPE: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION) 136
TABLE 121 EUROPE: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 137
TABLE 122 EUROPE: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 137
TABLE 123 EUROPE: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 138
TABLE 124 EUROPE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 138
10.3.1 GERMANY 139
10.3.1.1 Germany has witnessed a significant increase in investments in next-generation technologies, making it the largest market in Europe 139
TABLE 125 GERMANY: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION) 140
TABLE 126 GERMANY: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 140
TABLE 127 GERMANY: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 140
TABLE 128 GERMANY: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 141
TABLE 129 GERMANY: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 141
10.3.2 FRANCE 141
10.3.2.1 Government initiatives to support genomics research drive growth in the metagenomic sequencing market in France 141
TABLE 130 FRANCE: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION) 142
TABLE 131 FRANCE: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 142
TABLE 132 FRANCE: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 143
TABLE 133 FRANCE: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 143
TABLE 134 FRANCE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 144
10.3.3 UK 144
10.3.3.1 Favorable funding scenario for genomics research in the country to support the adoption of NGS 144
TABLE 135 UK: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION) 145
TABLE 136 UK: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION) 145
TABLE 137 UK: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 146
TABLE 138 UK: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 146
TABLE 139 UK: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
10.3.4 REST OF EUROPE 147
TABLE 140 ROE: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION) 147
TABLE 141 ROE: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 148
TABLE 142 ROE: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 148
TABLE 143 ROE: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 149
TABLE 144 ROE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 149
10.4 ASIA PACIFIC 149
FIGURE 27 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET SNAPSHOT 150
TABLE 145 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 151
TABLE 146 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2020–2027 (USD MILLION) 151
TABLE 147 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 151
TABLE 148 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 152
TABLE 149 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 152
TABLE 150 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 153
10.4.1 CHINA 153
10.4.1.1 Several key market players are focusing on strengthening their presence and offerings in China—a key factor driving market growth 153
TABLE 151 CHINA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION) 154
TABLE 152 CHINA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 154
TABLE 153 CHINA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 155
TABLE 154 CHINA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 155
TABLE 155 CHINA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Rising use of metagenomic sequencing for various applications to drive market growth in Japan 156
TABLE 156 JAPAN: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION) 157
TABLE 157 JAPAN: METAGENOMIC SEQUENCING MARKET, BY PRODUCT &
SERVICE, 2020–2027 (USD MILLION) 157
TABLE 158 JAPAN: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 158
TABLE 159 JAPAN: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 158
TABLE 160 JAPAN: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
10.4.3 INDIA 159
10.4.3.1 Increasing adoption of strategies such as collaborations and partnerships by various private and government bodies to drive market growth 159
TABLE 161 INDIA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION) 160
TABLE 162 INDIA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 160
TABLE 163 INDIA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 161
TABLE 164 INDIA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 161
TABLE 165 INDIA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
10.4.4 REST OF ASIA PACIFIC 162
TABLE 166 ROAPAC: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION) 163
TABLE 167 ROAPAC: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 163
TABLE 168 ROAPAC: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 163
TABLE 169 ROAPAC: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 164
TABLE 170 ROAPAC: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 164
10.4.5 LATIN AMERICA 164
10.4.5.1 Introduction of low-cost sequencing technologies is expected to drive the market 164
TABLE 171 LATAM: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION) 165
TABLE 172 LATAM: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 165
TABLE 173 LATAM: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 166
TABLE 174 LATAM: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 166
TABLE 175 LATAM: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 167
10.4.6 MIDDLE EAST & AFRICA 167
10.4.6.1 Rising awareness of advanced sequencing technologies is expected to drive market growth in the coming years 167
TABLE 176 MEA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION) 167
TABLE 177 MEA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 168
TABLE 178 MEA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 168
TABLE 179 MEA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 169
TABLE 180 MEA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
11 COMPETITIVE LANDSCAPE 170
11.1 KEY PLAYER STRATEGIES 170
FIGURE 28 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE METAGENOMIC SEQUENCING MARKET 171
11.2 MARKET SHARE ANALYSIS 172
FIGURE 29 METAGENOMIC SEQUENCING MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2020 172
TABLE 181 METAGENOMIC SEQUENCING MARKET: DEGREE OF COMPETITION 172
11.3 REVENUE ANALYSIS 173
FIGURE 30 REVENUE ANALYSIS FOR KEY COMPANIES (2018-2021) 173
11.4 COMPANY EVALUATION QUADRANT 174
FIGURE 31 METAGENOMIC SEQUENCING MARKET: COMPANY EVALUATION MATRIX, 2021 174
11.4.1 STARS 175
11.4.2 PERVASIVE PLAYERS 175
11.4.3 EMERGING LEADERS 175
11.4.4 PARTICIPANTS 175
11.5 COMPETITIVE LEADERSHIP MAPPING (START-UPS) 176
FIGURE 32 METAGENOMIC SEQUENCING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS, 2021 176
11.5.1 PROGRESSIVE COMPANIES 177
11.5.2 STARTING BLOCKS 177
11.5.3 DYNAMIC COMPANIES 177
11.5.4 RESPONSIVE COMPANIES 177
11.6 COMPETITIVE BENCHMARKING 177
TABLE 182 COMPANY PRODUCT FOOTPRINT (25 COMPANIES) 177
TABLE 183 COMPANY REGION FOOTPRINT (25 COMPANIES) 178
11.7 COMPETITIVE SCENARIO 179
11.7.1 PRODUCT LAUNCHES 179
TABLE 184 METAGENOMIC SEQUENCING MARKET: PRODUCT LAUNCHES,
JANUARY 2018-FEBRUARY 2022 179
11.7.2 DEALS 180
TABLE 185 METAGENOMIC SEQUENCING MARKET: DEALS,
JANUARY 2018-FEBRUARY 2022 180
11.7.3 OTHER DEVELOPMENTS 181
TABLE 186 METAGENOMIC SEQUENCING MARKET: OTHER DEVELOPMENTS,
JANUARY 2018-FEBRUARY 2022 181
12 COMPANY PROFILES 182
12.1 MAJOR PLAYERS 182
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 ILLUMINA, INC. 182
TABLE 187 ILLUMINA, INC.: BUSINESS OVERVIEW 182
FIGURE 33 ILLUMINA, INC.: COMPANY SNAPSHOT (2021) 183
12.1.2 THERMO FISHER SCIENTIFIC, INC. 188
TABLE 188 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 188
FIGURE 34 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021) 189
12.1.3 QIAGEN N.V. 194
TABLE 189 QIAGEN N.V.: BUSINESS OVERVIEW 194
FIGURE 35 QIAGEN N.V.: COMPANY SNAPSHOT (2020) 195
12.1.4 PERKINELMER, INC. 200
TABLE 190 PERKINELMER, INC.: BUSINESS OVERVIEW 200
FIGURE 36 PERKINELMER, INC.: COMPANY SNAPSHOT (2021) 201
12.1.5 OXFORD NANOPORE TECHNOLOGIES, PLC. 204
TABLE 191 OXFORD NANOPORE TECHNOLOGIES, PLC.: BUSINESS OVERVIEW 204
12.1.6 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 207
TABLE 192 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: BUSINESS OVERVIEW 207
FIGURE 37 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: COMPANY SNAPSHOT (2020) 208
12.1.7 BGI GROUP 212
TABLE 193 BGI GROUP: BUSINESS OVERVIEW 212
12.1.8 PSOMAGEN, INC. 215
TABLE 194 PSOMAGEN, INC.: BUSINESS OVERVIEW 215
12.1.9 EUROFINS SCIENTIFIC 217
TABLE 195 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW 217
FIGURE 38 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2020) 218
12.1.10 BROOKS AUTOMATION, INC. 220
TABLE 196 BROOKS AUTOMATION, INC.: BUSINESS OVERVIEW 220
FIGURE 39 BROOKS AUTOMATION, INC.: COMPANY SNAPSHOT (2020) 221
12.1.11 NOVOGENE CO., LTD. 223
TABLE 197 NOVOGENE CO., LTD.: BUSINESS OVERVIEW 223
12.1.12 ZYMO RESEARCH CORPORATION 225
TABLE 198 ZYMO RESEARCH CORPORATION: BUSINESS OVERVIEW 225
12.1.13 TECAN TRADING AG 227
TABLE 199 TECAN TRADING AG: BUSINESS OVERVIEW 227
FIGURE 40 TECAN TRADING AG: COMPANY SNAPSHOT (2020) 228
12.1.14 INTEGRAGEN SA 230
TABLE 200 INTEGRAGEN SA: BUSINESS OVERVIEW 230
FIGURE 41 INTEGRAGEN SA: COMPANY SNAPSHOT (2020) 230
12.1.15 MICROSYNTH AG 232
TABLE 201 MICROSYNTH AG: BUSINESS OVERVIEW 232
12.1.16 DNASTAR, INC. 234
TABLE 202 DNASTAR: BUSINESS OVERVIEW 234
12.2 OTHER COMPANIES 235
12.2.1 COSMOSID, INC. 235
TABLE 203 COSMOSID, INC.: COMPANY OVERVIEW 235
12.2.2 GENEXA AG 236
TABLE 204 GENEXA AG.: COMPANY OVERVIEW 236
12.2.3 VARIGEN BIOSCIENCES CORPORATION 236
TABLE 205 VARIGEN BIOSCIENCES: COMPANY OVERVIEW 236
12.2.4 VERITAS GENETICS 237
TABLE 206 VERITAS GENETICS: COMPANY OVERVIEW 237
12.2.5 SINGENE 237
TABLE 207 SINGENE: COMPANY OVERVIEW 237
12.2.6 METAGENOMI 238
TABLE 208 METAGENOMI: COMPANY OVERVIEW 238
12.2.7 COMPUTOMICS 238
TABLE 209 COMPUTOMICS: COMPANY OVERVIEW 238
12.2.8 IDBYDNA, INC. 239
TABLE 210 IDBYDNA, INC.: COMPANY OVERVIEW 239
12.2.9 INTACT GENOMICS, INC. 239
TABLE 211 INTACT GENOMICS, INC. COMPANY OVERVIEW 239
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 240
13.1 DISCUSSION GUIDE 240
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 244
13.3 AVAILABLE CUSTOMIZATIONS 246
13.4 RELATED REPORTS 246
13.5 AUTHOR DETAILS 247